204 related articles for article (PubMed ID: 12459339)
1. Short-term and long-term modulation of gene expression by antisense therapeutics.
Sazani P; Vacek MM; Kole R
Curr Opin Biotechnol; 2002 Oct; 13(5):468-72. PubMed ID: 12459339
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of antisense drugs: RNase H.
Crooke ST
Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):133-4. PubMed ID: 9593052
[No Abstract] [Full Text] [Related]
3. Is irrelevant cleavage the price of antisense efficacy?
Stein CA
Pharmacol Ther; 2000 Mar; 85(3):231-6. PubMed ID: 10739877
[TBL] [Abstract][Full Text] [Related]
4. Potent and selective inhibition of gene expression by an antisense heptanucleotide.
Wagner RW; Matteucci MD; Grant D; Huang T; Froehler BC
Nat Biotechnol; 1996 Jul; 14(7):840-4. PubMed ID: 9631007
[TBL] [Abstract][Full Text] [Related]
5. Morpholino antisense oligomers: the case for an RNase H-independent structural type.
Summerton J
Biochim Biophys Acta; 1999 Dec; 1489(1):141-58. PubMed ID: 10807004
[TBL] [Abstract][Full Text] [Related]
6. A short phosphodiester window is sufficient to direct RNase H-dependent RNA cleavage by antisense peptide nucleic acid.
Malchère C; Verheijen J; van der Laan S; Bastide L; van Boom J; Lebleu B; Robbins I
Antisense Nucleic Acid Drug Dev; 2000 Dec; 10(6):463-8. PubMed ID: 11198930
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of action of antisense drugs.
Crooke ST
Biochim Biophys Acta; 1999 Dec; 1489(1):31-44. PubMed ID: 10806995
[TBL] [Abstract][Full Text] [Related]
8. Antisense oligonucleotides.
Kashihara N; Maeshima Y; Makino H
Exp Nephrol; 1998; 6(1):84-8. PubMed ID: 9523178
[TBL] [Abstract][Full Text] [Related]
9. Novel mechanisms for antisense-mediated regulation of gene expression.
Baker BF; Monia BP
Biochim Biophys Acta; 1999 Dec; 1489(1):3-18. PubMed ID: 10806993
[No Abstract] [Full Text] [Related]
10. [Antisense strategies come of age].
Yokoyama K
Tanpakushitsu Kakusan Koso; 1993 Mar; 38(4):753-65. PubMed ID: 8475331
[No Abstract] [Full Text] [Related]
11. PAcM-AN: poly (N-acryloylmorpholine)-conjugated antisense oligonucleotides.
Bonora GM; De Franco AM; Rossin R; Veronese FM; Ferruti P; Plyasunova O; Vorobjev PE; Pyshnyi DV; Komarova NI; Zarytova VF
Nucleosides Nucleotides Nucleic Acids; 2000 Aug; 19(8):1281-8. PubMed ID: 11097058
[TBL] [Abstract][Full Text] [Related]
12. Making sense of antisense and interference.
Morrow T
Manag Care; 2003 Nov; 12(11):62-3. PubMed ID: 14666589
[No Abstract] [Full Text] [Related]
13. Application of 2'-O-(2-N-Methylcarbamoylethyl) Nucleotides in RNase H-Dependent Antisense Oligonucleotides.
Masaki Y; Iriyama Y; Nakajima H; Kuroda Y; Kanaki T; Furukawa S; Sekine M; Seio K
Nucleic Acid Ther; 2018 Oct; 28(5):307-311. PubMed ID: 30020852
[TBL] [Abstract][Full Text] [Related]
14. 2'-Modified oligonucleotides for antisense therapeutics.
Prakash TP; Bhat B
Curr Top Med Chem; 2007; 7(7):641-9. PubMed ID: 17430205
[TBL] [Abstract][Full Text] [Related]
15. RNase H sequence preferences influence antisense oligonucleotide efficiency.
Kielpinski LJ; Hagedorn PH; Lindow M; Vinther J
Nucleic Acids Res; 2017 Dec; 45(22):12932-12944. PubMed ID: 29126318
[TBL] [Abstract][Full Text] [Related]
16. Antisense oligonucleotides: the state of the art.
Aboul-Fadl T
Curr Med Chem; 2005; 12(19):2193-214. PubMed ID: 16178780
[TBL] [Abstract][Full Text] [Related]
17. Binding affinity and specificity of Escherichia coli RNase H1: impact on the kinetics of catalysis of antisense oligonucleotide-RNA hybrids.
Lima WF; Crooke ST
Biochemistry; 1997 Jan; 36(2):390-8. PubMed ID: 9003192
[TBL] [Abstract][Full Text] [Related]
18. Binary Antisense Oligonucleotide Agent for Cancer Marker-Dependent Degradation of Targeted RNA.
Drozd VS; Eldeeb AA; Kolpashchikov DM; Nedorezova DD
Nucleic Acid Ther; 2022 Oct; 32(5):412-420. PubMed ID: 35852843
[TBL] [Abstract][Full Text] [Related]
19. Potent gene-specific inhibitory properties of mixed-backbone antisense oligonucleotides comprised of 2'-deoxy-2'-fluoro-D-arabinose and 2'-deoxyribose nucleotides.
Lok CN; Viazovkina E; Min KL; Nagy E; Wilds CJ; Damha MJ; Parniak MA
Biochemistry; 2002 Mar; 41(10):3457-67. PubMed ID: 11876654
[TBL] [Abstract][Full Text] [Related]
20. XRN2 is required for the degradation of target RNAs by RNase H1-dependent antisense oligonucleotides.
Hori S; Yamamoto T; Obika S
Biochem Biophys Res Commun; 2015 Aug; 464(2):506-11. PubMed ID: 26159921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
